Delivery Order SPE2DB20D2002-SPE2DB24FL73E

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,802.00, is for the delivery of IPOL VIAL 5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $17,077.60 firm fixed-price contract is for the delivery of 4565332558 IPOL VIAL 5ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70. The contract has an ultimate completion date of October 7, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The contract has a ceiling value of $102,390.83 and an ultimate completion date of September 23, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide a wide range of pharmaceutical...
This $9,666.40 firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a performance period ending on September 10, 2024. This delivery order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, which has a potential value of $2,134.70, is for the delivery of IPOL VIAL 5ML pharmaceutical products to support military treatment programs and facilities. The contract does not have a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,808.20 firm fixed price contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a completion date of November 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a firm fixed-price delivery order award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4565244124 IPOL VIAL 5ML, with a ceiling value of $2,461.60 and a period of performance through July 25, 2024. Amerisourcebergen is a for-profit organization that holds several indefinite delivery contracts (IDCs) with the DLA and Department of Justice,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The $1,796.20 contract has an ultimate completion date of August 23, 2022. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $42,694.00 firm fixed-price order is for the supply of 4564557634 IPOL VIAL 5ML, a pharmaceutical product, with a period of performance ending on May 10, 2024. Amerisourcebergen holds a single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL73E
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of IPOL VIAL 5ML pharmaceutical products, with a ceiling value of $21,347.00 and a period of performance through July 31, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/29/24, 9:08 AM